Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine

NCT01980836 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Rheumatoid Arthritis
Cellular Immune Response

Interventions

BIOLOGICAL: Seasonal influenza vaccine

Sponsor

Tel-Aviv Sourasky Medical Center